PETALING JAYA: It is only the new enrollment of patients for hydroxychloroquine treatment under the Covid-19 global trial that has been temporarily suspended, says the World Health Organisation (WHO) representative to Malaysia.
Dr Jacqueline Lo Ying-Ru, Head of Mission and WHO representative to Malaysia, Brunei and Singapore, clarified that patients who had previously enrolled under the trial would finish their hydroxychloroquine treatment.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!